BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

950 related articles for article (PubMed ID: 9054052)

  • 41. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
    Martins C; Lacerda JF; Lourenço F; Carmo JA; Lacerda JM
    Acta Med Port; 2005; 18(5):329-37. PubMed ID: 16611537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia.
    Specchia G; Pastore D; Carluccio P; Liso A; Mestice A; Rizzi R; Ciuffreda L; Pietrantuono G; Liso V
    Ann Hematol; 2005 Nov; 84(12):792-5. PubMed ID: 16047203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
    de Lima M; van Besien K; Gajewski J; Khouri I; Andersson B; Korbling M; Champlin R; Giralt S
    Bone Marrow Transplant; 2000 Aug; 26(3):333-8. PubMed ID: 10967575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.
    Thomas X; Boiron JM; Huguet F; Dombret H; Bradstock K; Vey N; Kovacsovics T; Delannoy A; Fegueux N; Fenaux P; Stamatoullas A; Vernant JP; Tournilhac O; Buzyn A; Reman O; Charrin C; Boucheix C; Gabert J; Lhéritier V; Fiere D
    J Clin Oncol; 2004 Oct; 22(20):4075-86. PubMed ID: 15353542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
    Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
    Fukushima T; Ueda T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced-intensity cord blood transplantation without prior remission induction therapy induces durable remission in adult patients with relapsed acute leukemia after the first allogeneic transplantation.
    Ueki T; Sumi M; Sato K; Shimizu I; Akahane D; Ueno M; Ichikawa N; Nakao S; Kobayashi H
    Eur J Haematol; 2011 Mar; 86(3):268-71. PubMed ID: 21114536
    [No Abstract]   [Full Text] [Related]  

  • 48. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC).
    Houtenbos I; Bracho F; Davenport V; Slack R; van de Ven C; Suen Y; Killen R; Shen V; Cairo MS
    Bone Marrow Transplant; 2001 Jan; 27(2):145-53. PubMed ID: 11281383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent trends in the treatment and prognosis of adult leukemia with characteristics of patients in Japan: transition during the fifteen years from 1971 to 1985.
    Suzuki H; Ota K; Ohno R; Masaoka T; Shibata H; Kimura I; Amaki I; Miura Y; Uzuka Y; Kawato M
    Jpn J Clin Oncol; 1989 Dec; 19(4):338-47. PubMed ID: 2607637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
    Ayash LJ; Ratanatharathorn V; Braun T; Silver SM; Reynolds CM; Uberti JP
    Am J Hematol; 2007 Jan; 82(1):6-14. PubMed ID: 16986128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of acute leukemia with allogeneic stem cell transplantation].
    Seiwerth RS; Mrsić M; Nemet D; Bogdanić V; Mikulić M; Sertić D; Grković L; Cecuk E; Bojanić I; Batinić D; Labar B
    Acta Med Croatica; 2009 Jun; 63(3):205-8. PubMed ID: 19827346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia.
    Arcese W; Meloni G; Giona F; Vegna ML; Testi AM; Annino L; Iori AP; Carotenuto M; Resegotti L; Madon E
    Bone Marrow Transplant; 1991; 7 Suppl 2():38. PubMed ID: 1878711
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effectiveness of allogeneic bone marrow transplantation in patients with acute leukemia in complete remission and in patients with chronic myeloid leukemia during the chronic phase].
    Liubimova LS; Savchenko VG; Mendeleeva LP; Kliasova GA; Gribanova EO; Demidova IA; Gal'tseva IV; Kuz'mina LA; Momotiuk KS; Kuliev RG
    Ter Arkh; 1999; 71(7):27-32. PubMed ID: 10481864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
    Eapen M; Rubinstein P; Zhang MJ; Camitta BM; Stevens C; Cairo MS; Davies SM; Doyle JJ; Kurtzberg J; Pulsipher MA; Ortega JJ; Scaradavou A; Horowitz MM; Wagner JE
    J Clin Oncol; 2006 Jan; 24(1):145-51. PubMed ID: 16382124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapy of adult acute lymphoblastic leukemia].
    Bernasconi C
    Haematologica; 1991 Jun; 76 Suppl 3():58-64. PubMed ID: 1752544
    [No Abstract]   [Full Text] [Related]  

  • 57. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients.
    Carella AM; Piatti G; Frassoni F; Maraone MP; Van Lint MT; Bacigalupo A
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469
    [No Abstract]   [Full Text] [Related]  

  • 58. [Acute leukemia in childhood].
    Fink FM; Gadner H
    Wien Med Wochenschr; 1991; 141(9-10):190-5. PubMed ID: 1949840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment for adult acute myeloid leukemia: where we stand in 1995.
    Wiernik PH
    Acta Haematol Pol; 1995; 26(3):231-7. PubMed ID: 8525767
    [No Abstract]   [Full Text] [Related]  

  • 60. Chemotherapy versus allogeneic or autologous bone marrow transplantation in second complete remission of acute lymphoblastic leukemia.
    Herve P; Bordigoni P; Plouvier E
    Leukemia; 1992 Nov; 6 Suppl 4():59-61. PubMed ID: 1434835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.